Global Carrier Screening Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Carrier Screening Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Type (Expanded Carrier Screening, and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, and Others), End User (Hospitals and clinics, Reference Laboratories, Physician Offices, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Carrier Screening Market was valued at USD 3,107.7 million in 2023 and is expected to reach USD 9,245.3 million by 2031 while growing at a CAGR of 14.6% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global carrier screening market growth. Carrier screening, a genetic test, identifies individuals carrying gene mutations linked to genetic disorders, typically before having children. It assesses the risk of passing on such disorders, often recommended for those with family history, specific ethnicities, or planning a family.
Advances in genetic testing technologies, such as next-generation sequencing (NGS), coupled with increased awareness, drive the carrier screening market. However, the cost of testing and ethical and psychological concerns serve as hindrances to market growth.
Furthermore, the global carrier screening industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Type Analysis
The Global Carrier Screening Market is segmented among Expanded Carrier Screening, and Targeted Disease Carrier Screening, based on Type. In 2023, Expanded Carrier Screening accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Technology Analysis
The Global Carrier Screening Market is segmented among DNA Sequencing, Polymerase Chain Reaction, Microarrays, and Others, based on Technology. In 2023, DNA Sequencing accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Carrier Screening Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Fulgent Genetics Inc., Diasorin S.p.A., Illumina Inc., Myriad Genetics, Inc., Natera Inc., Eurofins Scientific, InVitae Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Inc., and Opko Health Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Carrier Screening Market Dynamics
Drivers
Restraints
Opportunity
4. Global Carrier Screening Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Carrier Screening Market Segmentation, By Type
Global Carrier Screening Market Share Analysis, By Type
Global Carrier Screening Market Growth Analysis, By Type
Global Carrier Screening Market Trends, By Type
o Expanded Carrier Screening
o Targeted Disease Carrier Screening
6. Global Carrier Screening Market Segmentation, By Technology
Global Carrier Screening Market Share Analysis, By Technology
Global Carrier Screening Market Growth Analysis, By Technology
Global Carrier Screening Market Trends, By Technology
o DNA Sequencing
o Polymerase Chain Reaction
o Microarrays
o Others
7. Global Carrier Screening Market Segmentation, By End User
Global Carrier Screening Market Share Analysis, By End User
Global Carrier Screening Market Growth Analysis, By End User
Global Carrier Screening Market Trends, By End User
o Hospitals and clinics
o Reference Laboratories
o Physician Offices
o Others
8. Global Carrier Screening Market Segmentation, By Region
Global Carrier Screening Market Share Analysis, By Region
Global Carrier Screening Market Growth Analysis, By Region
Global Carrier Screening Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Fulgent Genetics Inc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Diasorin S.p.A.
Illumina Inc.
Myriad Genetics, Inc.
Natera Inc.
Eurofins Scientific
InVitae Corporation
Thermo Fisher Scientific Inc.
Quest Diagnostics Inc.
Opko Health Inc.
*Similar analysis will be provided for each company listed above.
